262 related articles for article (PubMed ID: 35371813)
1. Facial Diplegia Variant of Guillain-Barré Syndrome in Pregnancy Following COVID-19 Vaccination: A Case Report.
Zubair AS; Bae JY; Desai K
Cureus; 2022 Feb; 14(2):e22341. PubMed ID: 35371813
[TBL] [Abstract][Full Text] [Related]
2. Acute motor-sensory axonal polyneuropathy variant of Guillain-Barré syndrome with a thalamic lesion and COVID-19: a case report and discussion on mechanism.
Geng N; Wang P; Zhang Y
Front Neurol; 2023; 14():1227505. PubMed ID: 37780717
[TBL] [Abstract][Full Text] [Related]
3. Guillain-Barré Syndrome Presenting as Facial Diplegia after COVID-19 Vaccination: A Case Report.
Rossetti A; Gheihman G; O'Hare M; Kosowsky JM
J Emerg Med; 2021 Dec; 61(6):e141-e145. PubMed ID: 34538679
[TBL] [Abstract][Full Text] [Related]
4. [Isolated facial diplegia as an atypical variant of Guillain-Barre syndrome after suspected SARS-CoV-2 infection].
Lavilla Olleros C; López-Rubio M; Fanciulli C; González-Munera A; Millán Núñez-Cortés J
Rev Fac Cien Med Univ Nac Cordoba; 2021 Dec; 78(4):405-407. PubMed ID: 34962738
[TBL] [Abstract][Full Text] [Related]
5. Facial diplegia, a possible atypical variant of Guillain-Barré Syndrome as a rare neurological complication of SARS-CoV-2.
Juliao Caamaño DS; Alonso Beato R
J Clin Neurosci; 2020 Jul; 77():230-232. PubMed ID: 32410788
[TBL] [Abstract][Full Text] [Related]
6. Facial Diplegia as the Sole Manifestation of Post-Vaccination Guillain-Barre Syndrome: A Case Report and Literature Review.
Prado MB; Adiao KJB
Neurohospitalist; 2022 Jul; 12(3):508-511. PubMed ID: 35755217
[TBL] [Abstract][Full Text] [Related]
7. A Novel Case of Bifacial Diplegia Variant of Guillain-Barré Syndrome Following Janssen COVID-19 Vaccination.
Prasad A; Hurlburt G; Podury S; Tandon M; Kingree S; Sriwastava S
Neurol Int; 2021 Aug; 13(3):404-409. PubMed ID: 34449715
[TBL] [Abstract][Full Text] [Related]
8. Miller-Fisher Syndrome and Guillain-Barre Syndrome overlap syndrome in a patient post Oxford-AstraZeneca SARS-CoV-2 vaccination.
Dang YL; Bryson A
BMJ Case Rep; 2021 Nov; 14(11):. PubMed ID: 34848426
[TBL] [Abstract][Full Text] [Related]
9. A 50-Year-Old Patient with Guillain-Barré Syndrome after COVID-19: A Case Report.
Chmiela T; Rzepka M; Krzystanek E; Gorzkowska A
Medicina (Kaunas); 2021 Jul; 57(8):. PubMed ID: 34440980
[TBL] [Abstract][Full Text] [Related]
10. A 44-Year-Old Hispanic Man with Loss of Taste and Bilateral Facial Weakness Diagnosed with Guillain-Barré Syndrome and Bell's Palsy Associated with SARS-CoV-2 Infection Treated with Intravenous Immunoglobulin.
Khaja M; Gomez GPR; Santana Y; Hernandez N; Haider A; Lara JLP; Elkin R
Am J Case Rep; 2020 Oct; 21():e927956. PubMed ID: 33128540
[TBL] [Abstract][Full Text] [Related]
11. Facial Diplegia: A Rare, Atypical Variant of Guillain-Barré Syndrome and Ad26.COV2.S Vaccine.
Jain E; Pandav K; Regmi P; Michel G; Altshuler I
Cureus; 2021 Jul; 13(7):e16612. PubMed ID: 34447646
[TBL] [Abstract][Full Text] [Related]
12. Guillain-Barré syndrome AMSAN variant in a 90-year-old woman after COVID-19: a case report.
Sidoli C; Bruni AA; Beretta S; Mazzola P; Bellelli G
BMC Geriatr; 2023 Mar; 23(1):114. PubMed ID: 36859256
[TBL] [Abstract][Full Text] [Related]
13. Loss of Taste as an Initial Symptom of a "Facial Diplegia and Paresthesia" Variant of Guillain-Barré Syndrome.
Hiraga A; Muto M; Kuwabara S
Intern Med; 2022 Oct; 61(19):2957-2959. PubMed ID: 35908975
[TBL] [Abstract][Full Text] [Related]
14. Acute-onset chronic inflammatory demyelinating polyneuropathy complicating SARS-CoV-2 infection and Ad26.COV2.S vaccination: report of two cases.
Fotiadou A; Tsiptsios D; Karatzetzou S; Kitmeridou S; Iliopoulos I
Egypt J Neurol Psychiatr Neurosurg; 2022; 58(1):116. PubMed ID: 36212671
[TBL] [Abstract][Full Text] [Related]
15. Bilateral facial palsy with paresthesias, variant of Guillain-Barré syndrome following COVID-19 vaccine: A case series of 9 patients.
Castiglione JI; Crespo JM; Lecchini L; Silveira FO; Luis MB; Cotti N; Simison CJ; Aguirre F; Piedrabuena MA; Alonso RN; Azcona CL; Sosa PS; Maldonado E; Barroso F
Neuromuscul Disord; 2022 Jul; 32(7):572-574. PubMed ID: 35644722
[TBL] [Abstract][Full Text] [Related]
16. A Rare Variant of Guillain-Barre Syndrome Following Ad26.COV2.S Vaccination.
Morehouse ZP; Paulus A; Jasti SA; Bing X
Cureus; 2021 Sep; 13(9):e18153. PubMed ID: 34703690
[TBL] [Abstract][Full Text] [Related]
17. Concomitant Guillain-Barre syndrome with COVID-19: a case report.
Mackenzie N; Lopez-Coronel E; Dau A; Maloof D; Mattar S; Garcia JT; Fontecha B; Lanata CM; Guillen-Burgos HF
BMC Neurol; 2021 Mar; 21(1):135. PubMed ID: 33757457
[TBL] [Abstract][Full Text] [Related]
18. Two Case Reports of Chronic Inflammatory Demyelinating Polyneuropathy After COVID-19 Vaccination.
Kim S; Lee EK; Sohn E
J Korean Med Sci; 2023 Feb; 38(8):e57. PubMed ID: 36852853
[TBL] [Abstract][Full Text] [Related]
19. A Case of Guillain-Barré Syndrome Associated With COVID-19.
Rajdev K; Victor N; Buckholtz ES; Hariharan P; Saeed MA; Hershberger DM; Bista S
J Investig Med High Impact Case Rep; 2020; 8():2324709620961198. PubMed ID: 32981333
[TBL] [Abstract][Full Text] [Related]
20. A Clinical Case of COVID-19 Vaccine-Associated Guillain-Barré Syndrome.
Hilts A; Schreiber A; Singh A
Am J Case Rep; 2022 Aug; 23():e936896. PubMed ID: 35945825
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
